MicroPort CRM
Clinical trials sponsored by MicroPort CRM, explained in plain language.
Now part of
MicroPort Scientific Corporation
0853
HKEX
A subsidiary of MicroPort Scientific, specializing in cardiac rhythm management devices.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New heart lead put to the test in 450 patients Results expected Jan 2027 (estimated)